Vironix remote physiological monitoring & disease-specific AI intelligence for respiratory and cardiovascular chronic illnesses
Either you or someone you know has been impacted by heart or lung disease.
17.9 MILLION PEOPLE
die each year from cardiovascular disease.
That’s one death every 56 seconds.
People diagnosed with or at risk of heart failure, COPD, asthma, & acute respiratory illness face constant risk of death, hospitalization, massive healthcare expenditures, and persistent anxiety. If detected and managed early, singular health deterioration episodes, which include exacerbations & infections, can be readily addressed at home with diet, medications, and rest.
is the cost of preventable heart and lung disease to employers and health insurance providers
Peer-Reviewed, World Class R&D
Clinically validated algorithms built by scientists and clinicians.
Vironix Health intern student, James Morrill at University of Oxford was awarded the prestigious Reddick Prize
Vironix Health intern & student, James Morrill at University of Oxford was awarded the prestigious Reddick Prize !!!
Welcoming Ahmed Ammar Naseer to Vironix Health
University of Oxford Masters Student, Ahmed Ammar Naseer, has joined Vironix’s modelling team to work on synthetic patient data generation and machine learning algorithms for predicting heart failure exacerbations. The results and methodologies developed in his internship project may help patients to improve their quality of life and reduce preventable emergency care episodes.
Welcoming Fareeha Shah To The Team
Fareeha is a UX/UI/Design expert who has just come aboard. She will be working on improving the company’s externally facing materials (product UI/UX, website, social media, etc).
Vironix was formed by passionate scientists, physicians, technologists, and entrepreneurs who have amassed decades of research, development, and commercialization expertise in the development, testing, and commercialization of medical technology.